MYH11 and acute myeloid leukemia: In summary, our study suggests that the CBFβ-MYH11 fusion maintains inv(16) AML cells by attenuating expression levels of GATA2 and blocks their further differentiation towards Mega/Ery lineages via interfering with a GATA2/KLF1-involved regulatory network.